Related Experiment Video
Updated: May 2, 2026

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
Dabigatran anticoagulation and Stanford type A aortic dissection: lethal coincidence: Case report with literature
1Institute of Anaesthesiology, University and University Hospital of Zurich, Zurich, Switzerland.
Background:
Novel oral anticoagulants are now encountered in patients needing emergency surgery. Knowledge and treatment options are limited.
Methods And Result:
We present the case of a 76-year-old patient who suffered from an acute Stanford type A aortic dissection, needing emergency surgical aortic repair. He was anticoagulated with dabigatran due to past atrial fibrillation. Despite haemodiafiltration, surgical revision and massive transfusion of packed red blood cells, fresh frozen plasma, platelets, coagulation factors, and recombinant factor VIIa, the patient died from intractable bleeding with sustained therapeutic levels of dabigatran.
Conclusion:
After reviewing the literature, we summarize the limited treatment options and show possible approaches for patients treated with dabigatran needing emergency surgery.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Aneurysm III: Interprofessional Care
Aortic Regurgitation I: Introduction
Venous Thrombosis III: Interprofessional Care

